News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
Publication
Dermatology Times
More
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
    • Biologic Treatments for Moderate to Severe Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
    • Emerging Therapies Plaque Psoriasis
    • Treatments for Plaque Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Skin Cancer (Nonmelanoma)
  • Vitiligo
  • Wound Care
Spotlight -
NP and PA
Advertisement

Victoria Maloney, PA-C

Advertisement

Articles by Victoria Maloney, PA-C

3 Things You Should Know About the Pathogenesis and Treatment of HS

ByPER Editorial Staff,Renata Block, DMSc, MMS, PA-C,TJ Chao, MPAS, PA-C,Victoria Maloney, PA-C
January 2nd 2024

This CME credit opportunity delves into the pathogenesis and management of hidradenitis suppurativa.

Advertisement

Latest Updated Articles

  • 3 Things You Should Know About the Pathogenesis and Treatment of HS
    3 Things You Should Know About the Pathogenesis and Treatment of HS

    Published: January 2nd 2024 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria

2

KT-621 Produces 98% STAT6 Degradation in AD Patients

3

Site-Specific MED Variability Guides 308-nm Excimer Laser Dosing

4

Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema

5

Impaired HRQoL and High Psychological Comorbidity Observed in Japanese Vitiligo Patients

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us